Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 6.45 | N/A |
| PEG Ratio (TTM) | -0.49 | N/A |
| P/S Ratio (TTM) | 0.10 | N/A |
| P/B Ratio (TTM) | 0.11 | N/A |
| P/FCF Ratio (TTM) | 2.11 | N/A |
| Price to 5YR AVG Earnings Ratio | 5.75 | N/A |
| Price to 5YR AVG FCF Ratio | 2.27 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.64% | N/A |
| ROE (TTM) | 3.72% | N/A |
| Net Profit Margin (TTM) | 1.47% | N/A |
| ROIC 5YR AVG | 6.54% | N/A |
Growth (78%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 94.62% | 190.58% | 473.85% |
| Revenue | 3.37% | 0.14% | -1.98% |
| Net Income | 94.63% | 179.38% | 440.91% |
| Cash Flow | 968.36% | 9.71% | 51.15% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.05 | N/A |
| Quick Ratio (TTM) | 0.12 | N/A |
| D/E Ratio (TTM) | 0.20 | N/A |
| Interest Coverage (TTM) | 1.85 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 1.35 | N/A |
| LTL to 5YR AVG FCF | 10.09 | N/A |
| Shares Outstanding Growth 5YR AVG | -7.50% | N/A |